Proteolysis targeting chimeras (PROTACs), understood for their capability to engage with previously undruggable targets, are rising in appeal as cancer rehabs. Carrying out biophysical assays to quantify the strength of a degraders molecular interactions with binding partners is challenging due to aspects including little sample amounts, absence of mass changes upon target binding, and complicated protocols. Researchers can simplify and quickly perform these binding assays utilizing Spectral Shift innovation on NanoTempers Dianthus platform.Download this webinar from NanoTemper to find out how researchers rapidly identified PROTAC ternary and binary interactions utilizing Spectral Shift technology.Sponsored by
